Sensors for Health Monitoring | Non-Wearable Health Devices – Cardi/o® by Advanced TeleSensors, Inc.

Sensing Life,
with No Contact

About Advanced Telesensors

We envision a world where people can access their physiology data without being attached to a foreign object, poked, prodded, or tracked unnecessarily. Sensing life with no contact is the first advancement into this “touchless” world.

We use this advancement in radar technology to sense vital signs naturally transmitted by the human body and convert them into measurable data: heart rate, respiratory rate, stress (heart rate variability), and motion. These vital signs tell a “personal story” of individual health.

Totally Touchless Cardi/o® by Advanced Telesensors delivers these “personal stories” in an easy and comfortable way regardless of age, lifestyle, or technical know-how. Anyone can just step into the Cardi/o® “zone” in their own home and know their stats; then step out when they’re done. No wires, no patches, nor trackers required.

Our Values

We strive to uphold comfort, privacy, and individual empowerment supported by data for a better future.

Management Team

Sajol Ghoshal

CEO and president

SAJOL GHOSHAL, CEO and President

Sajol is a serial executive with three success exits totaling $3B. He brings more than 30 years of leadership, strategy, and engineering experience driving innovative sensing solutions. His contemplation of emerging technologies and growth trends offers keen insight toward solving efficiency gaps, product positioning and adoption, which he executed over the span of his career developing innovative technology with startups, Level One Communications sold to Intel for $2.2B, Agere sold to Lucent for $450M and TAOS sold to AMS for $350M.

Trudy Leal

VP of Sales & Business Development

TRUDY LEAL, VP of Sales & Business Development

Trudy Leal brings over 20 years of experience in the medical device industry. She holds an MBA from Louisiana State University-Shreveport, with concentrations in marketing and international business. Fluent in English, Spanish, and French, Trudy excels in networking and forging strategic partnerships. Her expertise has garnered over 20 awards for excellence in sales and consistently surpassing sales goals. Known for her dynamic approach, she has been instrumental in driving growth and bringing new business to companies through innovative marketing strategies. In addition to her professional achievements, Trudy serves on the board of Women In Healthcare, demonstrating her commitment to advancing the role of women in the industry.

Jason Zagrodzky, M.D.

Chief Medical Officer

Jason Zagrodzky, Doctor of Cardiology, Clinical Cardiac Electrophysiology

Dr. Zagrodzky has a broad background in human cardiology, with specific training and expertise in cardiac electrophysiology, atrial fibrillation, and ICD / pacemaker insertion. His background and expertise provide a fine understanding of human cardiology as it pertains to Cardi/o^® users.

Among his regulatory work, Dr. Zagrodzky served as Principal Investigator on a 12-month FDA Clinical Trial sponsored by Abbot Medical Devices. His contributions to science include the treatment of the first premature ventricular contraction case using a new cardiac mapping system to treat heart arrythmias at St. David’s Medical Center, and was a participant of the largest device study to date designed to evaluate the performance of Attune Medical’s ensoETM patient temperature management device as an aid in the reduction of esophageal injury during cardiac ablation. He is a past president of the Alpha Omega Alpha National Honor Medical Society and recipient of the Mayes-Smith Award in Internal Medicine.

Dr. Zagrodzky completed his Fellowship in Clinical Cardiac Electrophysiology at the University of Texas Southwestern Medical School, Dallas, TX and currently practices at Texas Cardiac Arrhythmia Institute (TCAI), St. David’s Medical Center in Austin, TX. He has Over 30 publications and presentations in medical journals covering cardiology topics, including The New England Journal of Medicine.

Elisa Maldonado-Holmertz

FDA Regulatory and Quality Assurance

Elisa Maldonado-Holmertz, FDA Regulatory and Quality Assurance

Elisa Maldonado-Holmertz is responsible for FDA regulatory affairs and quality assurance. Elisa has 25 years of leadership experience in the multinational biopharma and medical device industries. She has worked and lived in emerging and established markets including the USA, Belgium, Sweden, and the P.R. China. She successfully contributed at PPDI, Pfizer, Aerocrine, and Emergo Group, with responsibilities in pre-clinical, clinical, regulatory and quality functions. Elisa earned a BA from University of Texas at Austin, and has completed graduate work in Business Management and Health Economics.

Board of Directors

Kirk Laney

Director

KIRK LANEY, Director

Kirk Laney is a semiconductor professional with 30 years experience building teams and companies for successful exits. He spun off the Optoelectronic Products Group from Texas Instruments in 1998, and transformed the fledgling company – Texas Advanced Optoelectronic Solutions, Inc. (TAOS) – from a niche market provider to a worldwide leader and technology innovator of opto-sensor solutions. TAOS was acquired by publicly traded ams AG (SIX: AMS) in 2011, where Kirk served as interim CEO of TAOS-ams AG until 2017, and continued as Chief Strategy Officer on AMS’s Management Board at the expiration of his CEO term. In addition to Advanced TeleSensors, Kirk serves on the Board of Directors at Gain Semiconductors. Kirk Laney is a U.S. citizen and holds a Bachelor of Science degree in Physics from Midwestern State University and four patents in opto-electronic packaging.

Jacob Jacobsson

Chairman

JACOB JACOBSSON, Director

Jacob Jacobsson has held CEO positions at Blaze DFM, Inc., Forte Design Systems and SCS Corporation, and executive positions at Xilinx Inc., Cadence Design Systems, and Daisy Systems. He has served on the board of directors at Actel Corp. (Nasdaq: ACTL), and currently serves on the boards of directors of ams AG (SIX:AMS), RFMicron, Inc., Helic Inc., Runtime Inc., and is an angel investor and board member at a number of other privately held companies in the United States and Europe. Prior to his management career, Mr. Jacobsson was active in the fields of Integrated Circuit (IC) design and automated design of semiconductor chips. Mr. Jacobsson, a citizen of Sweden and the United States, holds M.S. degrees in Computer Science and Electrical Engineering from the Royal Institute of Technology (KTH, Stockholm) and a B.A. degree from the University of Stockholm.

Jack Syage, PHD.

Director

JACK SYAGE, PhD., Director

Jack is currently CEO of ImmunogenX, a company developing therapeutic and diagnostic solutions, and has over 25 years of experience in creating and leading the development of innovative technologies particularly in the field of analytical instrumentation. Previously he founded Syagen Technology, Inc. and led its growth culminating in the successful acquisition in 2011 by the $20B/yr French company Safran. He was then appointed Chief Scientist for the subsidiary Morpho Detection. In addition to Advanced Telesensors, Jack sits on the Board of Directors of ImmunogenX, Flamentera AG, PhageTech, and Appellation Ventures. Jack has published over 130 papers, delivered about 100 invited talks, has over 30 U.S. patents issued or pending and appears on the list of the Most Highly Cited Chemists. His honorary positions included Visiting Professor at UC Irvine, Visiting Professor at the Université de Paris-Sud, Editorial Board member of the Journal of Physical Chemistry, and invitee to the Nobel Symposium in Chemistry. He received his PhD from Brown University where he was awarded the Potter Prize for Best Thesis and went on to post doc at Caltech under Nobel Laureate Ahmed Zewail.